GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (LTS:0I3I) » Definitions » Cyclically Adjusted Price-to-FCF

The Cooper (LTS:0I3I) Cyclically Adjusted Price-to-FCF : 45.73 (As of Jun. 06, 2024)


View and export this data going back to 2018. Start your Free Trial

What is The Cooper Cyclically Adjusted Price-to-FCF?

As of today (2024-06-06), The Cooper's current share price is $94.67. The Cooper's Cyclically Adjusted FCF per Share for the quarter that ended in Apr. 2024 was $2.07. The Cooper's Cyclically Adjusted Price-to-FCF for today is 45.73.

The historical rank and industry rank for The Cooper's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

LTS:0I3I' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 30.03   Med: 51.53   Max: 72.19
Current: 45.55

During the past years, The Cooper's highest Cyclically Adjusted Price-to-FCF was 72.19. The lowest was 30.03. And the median was 51.53.

LTS:0I3I's Cyclically Adjusted Price-to-FCF is ranked worse than
53.59% of 237 companies
in the Medical Devices & Instruments industry
Industry Median: 43.19 vs LTS:0I3I: 45.55

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

The Cooper's adjusted free cash flow per share data for the three months ended in Apr. 2024 was $0.184. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $2.07 for the trailing ten years ended in Apr. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


The Cooper Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for The Cooper's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cooper Cyclically Adjusted Price-to-FCF Chart

The Cooper Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.09 49.96 57.36 33.38 37.72

The Cooper Quarterly Data
Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.63 46.81 37.72 45.09 43.05

Competitive Comparison of The Cooper's Cyclically Adjusted Price-to-FCF

For the Medical Instruments & Supplies subindustry, The Cooper's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Cooper's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where The Cooper's Cyclically Adjusted Price-to-FCF falls into.



The Cooper Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

The Cooper's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=94.67/2.07
=45.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Cooper's Cyclically Adjusted FCF per Share for the quarter that ended in Apr. 2024 is calculated as:

For example, The Cooper's adjusted Free Cash Flow per Share data for the three months ended in Apr. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Apr. 2024 (Change)*Current CPI (Apr. 2024)
=0.184/131.7762*131.7762
=0.184

Current CPI (Apr. 2024) = 131.7762.

The Cooper Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201407 0.266 100.520 0.349
201410 0.468 100.176 0.616
201501 0.076 98.604 0.102
201504 0.291 99.824 0.384
201507 0.150 100.691 0.196
201510 0.234 100.346 0.307
201601 0.227 99.957 0.299
201604 0.290 100.947 0.379
201607 0.499 101.524 0.648
201610 0.802 101.988 1.036
201701 0.403 102.456 0.518
201704 0.521 103.167 0.665
201707 0.587 103.278 0.749
201710 0.838 104.070 1.061
201801 -0.129 104.578 -0.163
201804 0.627 105.708 0.782
201807 0.920 106.324 1.140
201810 0.966 106.695 1.193
201901 0.113 106.200 0.140
201904 0.811 107.818 0.991
201907 0.605 108.250 0.736
201910 0.576 108.577 0.699
202001 0.305 108.841 0.369
202004 -0.320 108.173 -0.390
202007 0.342 109.318 0.412
202010 0.561 109.861 0.673
202101 0.462 110.364 0.552
202104 0.718 112.673 0.840
202107 0.905 115.183 1.035
202110 0.546 116.696 0.617
202201 0.546 118.619 0.607
202204 0.445 121.978 0.481
202207 1.095 125.002 1.154
202210 0.180 125.734 0.189
202301 0.421 126.223 0.440
202304 0.254 127.992 0.262
202307 0.259 128.974 0.265
202310 0.147 129.810 0.149
202401 0.023 130.124 0.023
202404 0.184 131.776 0.184

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


The Cooper  (LTS:0I3I) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


The Cooper Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of The Cooper's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


The Cooper (LTS:0I3I) Business Description

Traded in Other Exchanges
Address
6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.

The Cooper (LTS:0I3I) Headlines

No Headlines